2008

Important Information about Generic OxyContin®
June 13, 2008

NHLBI Guidelines and clinical studies suggest that Advair® and Symbicort® should be reserved for patients not adequately controlled on ICS products
May 30, 2008

Pharmacy Claims Processor Conversion Q&A
Recently you may have heard that RegenceRx has decided to partner with a new claims processing vendor
April 14, 2008

2007

The Delfini Group™, LLC, are leaders in evidence and value-based solutions in health care.
Regarding RegenceRx they have stated that they “know of no group today…that is doing a finer job applying evidence-based medicine principles.” Read about The Delfini Group and the RegenceRx process.s

FDA Alert – New Avandia Warning Information Reflects Possible Heart Attack Risk
The FDA informed healthcare professionals of new information about potential increased risk for heart attacks added to the existing boxed warning in Avandia's prescribing information.
November 20, 2007

MDeNews™ August 2007
Avandia^® and Cardiovascular Risk – Implications for Patients and Providers
August 29, 2007

FDA Alert – FDA Permits Restricted Zelnorm Use
The FDA announced it’s permitting restricted use of Zelnorm under investigational new drug treatment protocol.
July 30, 2007

MDeNews™  June 2007
Brand v. Generic Antidepressants for the Treatment of Depression: What Does the Evidence Really Say?
June 27, 2007

Generics First – Antidepressant Program
The antidepressant market has substantially changed over the last several years and more are available generically and for the majority of patients, generic SSRIs provide effective treatment.
May 7, 2007